Hydroxyapatite (幸运) nanorods 在各种各样的地里拥有广阔潜在的应用程序,并且这里,有高方面比率的幸运 nanorods 在气压下面在 60 °C 经由方便二阶段的降水水解作用进程被综合。在降水舞台的 CaHPO 4 的先锋很好作为表面活化剂与 CTAB 作为瘤多的形态学被使结晶,当 CaHPO 4 被溶解, CTA + 在水解作用阶段期间稳定了幸运原子核时。哦在 Ca 2+ 和 PO 43+ 反应了与的地方, − 离子被吸收到活跃水晶表面上哦让原子核长成更大的晶体的 − ,和高度水晶的幸运 nanorods 被 Ostwald 成熟获得。幸运晶体上的 IBU 的装载的药能百分之百在 24 h 被释放。PVP 修改了幸运 nanorods 罐头增加比纯幸运 nanorods 快的装载药的能力和版本药。结果显示与合适的表面活化剂修改的幸运 nanorods 具有在药交货系统的大使用。
Hydroxyapatite (HAp) nanorods possess vast potential applications in various fields, and here HAp nanorods with high aspect ratio were synthesized via a convenient two-stage precipitation-hydrolysis process at 60℃ under atmospheric pressure. The precursor of CaHPO4 at precipitation stage is well crystallized as nubby morphology with CTAB as surfactant, while CaHPO4 was dissolved and CTA+ stabilized the HAp nuclei during the hydrolysis stage. OH- ions were absorbed onto the active crystal surface, where Ca2+ and PO4 3- reacted with OH- to make the nuclei grow into larger crystals, and highly crystalline HAp nanorods were obtained by Ostwald ripening. The loaded drug of IBU on the HAp crystals can be 100% released in 24 h. PVP modified HAp nanorods can increase the drug-loading capacity and release drug faster than pure HAp nanorods. The results indicate that HAp nanorods modified with suitable surfactants are of great use in drug delivery system.